Dolby Laboratories Sees Q3 Adj EPS $0.56-$0.71 vs $0.98 Est; Sees Sales $295.000M-$325.000M vs $343.538M Est

Benzinga Newsdesk www.benzinga.com Neutral 74.7%

Neg 0% Neu 74.7% Pos 0%

Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. sees sales of $295.000 million-$325.000 million vs $343.538 million analyst estimate.